Skip to main content

Pemphigus Vulgaris News

FDA Approves Genentech’s Rituxan (rituximab) for Pemphigus Vulgaris

South San Francisco, CA – June 7, 2018 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Rituxan...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related drug support groups

Rituxan, rituximab